All Stories

  1. The subjective effects of gabapentin are like depressants with abuse potential.
  2. Lack of sex and estrous stage effects on compulsive behavior assessed using a schedule-induced polydipsia procedure in rats
  3. Assessment of antidepressant-like effects of dextromethorphan on differential reinforcement of low-rate 72-s performance in rats
  4. Conditioned Place Preference Test for Assessing the Rewarding Effects of Drugs of Abuse
  5. Drug Discrimination: Historical Origins, Important Concepts, and Principles
  6. The Neurotensin NTS1 Receptor Agonist PD149163 Produces Antidepressant‐Like Effects in the Forced Swim Test: Further Support for Neurotensin as a Novel Pharmacologic Strategy for Antidepressant Drugs
  7. Neurotensin NTS 1 and NTS 2 receptor agonists produce anxiolytic-like effects in the 22-kHz ultrasonic vocalization model in rats
  8. Translational Value of Drug Discrimination with Typical and Atypical Antipsychotic Drugs
  9. Discriminative stimulus properties of 1.25 mg/kg clozapine in rats: Mediation by serotonin 5-HT 2 and dopamine D 4 receptors
  10. The Discriminative Stimulus Properties of Drugs Used to Treat Depression and Anxiety
  11. The antidepressant drugs fluoxetine and duloxetine produce anxiolytic-like effects in a schedule-induced polydipsia paradigm in rats
  12. The quetiapine active metabolite N-desalkylquetiapine and the neurotensin NTS₁ receptor agonist PD149163 exhibit antidepressant-like effects on operant responding in male rats.
  13. The Discriminative Stimulus Effects of the Neurotensin NTS1Receptor Agonist PD149163 in Rats: Stimulus Generalization Testing with Dopamine D1and D2Receptor Ligands
  14. Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats
  15. Systemic administration of the neurotensin NTS₁-receptor agonist PD149163 improves performance on a memory task in naturally deficient male Brown Norway rats.
  16. Effects of the neurotensin NTS1 receptor agonist PD149163 on visual signal detection in rats
  17. Assessment of attention in male and female Brattleboro rats using a self-paced five-choice serial reaction time task
  18. The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats
  19. Evaluation of the effects of α2 adrenoceptor antagonism with the D2 receptor antagonist raclopride on conditioned avoidance responding in rats
  20. Discriminative stimulus properties of idazoxan: mediation by both α2 adrenoceptor antagonism and 5‐HT1A receptor agonism
  21. Differential Effects of M1 and 5-Hydroxytryptamine1A Receptors on Atypical Antipsychotic Drug-Induced Dopamine Efflux in the Medial Prefrontal Cortex
  22. Drug discrimination: 30 years of progress
  23. Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT2A serotonergic and α1 adrenergic antagonism
  24. Acute nicotine reduces and repeated nicotine increases spontaneous activity in male and female Lewis rats
  25. Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies
  26. The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats
  27. Acute behavioral tolerance to nicotine in the conditioned taste aversion paradigm
  28. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: Potentiation of risperidone-, but not haloperidol-, induced dopamine efflux
  29. AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus
  30. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus
  31. NK3 receptor antagonists for the treatment of schizophrenia
  32. Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25???mg/kg clozapine vs. 5.0???mg/kg clozapine vs. vehicle
  33. Serotonergic mechanisms in schizophrenia: Evolution and current concepts
  34. Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination task
  35. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens
  36. Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice
  37. Generalization testing with atypical and typical antipsychotic drugs in rats trained to discriminate 5.0 mg/kg clozapine from vehicle in a two-choice drug discrimination task
  38. Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats
  39. Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms
  40. Reevaluation of PNU-99194A discriminative stimulus effects
  41. Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D 3 preferring antagonist PNU-99194A: an analysis of possible mechanisms